Tomatine inhibits ERK, PI3K/AKT, and NF-κB pathways that can be implicated in inhibiting HepG2 cell proliferation, apoptotic induction, and in vivo tumor growth (Shih et al., 2009; Lee et al., 2013b; Bailly, 2021). The gene discussed is AKT1; the disease is neoplasm.